XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Sep. 27, 2024
Sep. 29, 2023
Sep. 30, 2022
Cash flows from operating activities of Continuing Operations:      
Net income from Continuing Operations $ 261,893 $ 447,098 $ 38,781
Adjustments to reconcile Net income from Continuing Operations to Net cash provided by operating activities of Continuing Operations:      
Depreciation and amortization 435,547 409,857 397,975
Asset write-downs 18,186 29,865 0
Reduction of contingent consideration liability (see Note 17) (8,710) (97,336) (20,749)
Gain on equity investments, net (see Note 1) (25,071) (375,972) 0
Deferred income taxes (7,323) 100,158 15,908
Share-based compensation expense 62,552 76,337 82,299
Changes in operating assets and liabilities:      
Receivables, net (99,788) (177,873) (410,803)
Inventories (3,826) (35,333) (77,430)
Prepayments and other current assets (2,660) (9,352) (1,197)
Accounts payable 105,868 115,437 392,343
Accrued expenses 14,420 87,206 40,742
Payments made to clients on contracts (139,003) (119,217) (56,865)
Changes in other noncurrent liabilities (1,222) 16,313 17,097
Changes in other assets 58,929 43,187 35,278
Other operating activities 56,722 1,272 10,534
Net cash provided by operating activities of Continuing Operations 726,514 511,647 463,913
Cash flows from investing activities of Continuing Operations:      
Purchases of property and equipment and other (427,425) (383,536) (311,948)
Disposals of property and equipment 23,945 18,060 16,326
Purchases of marketable securities (113,303) (109,998) (78,220)
Proceeds from marketable securities 186,371 80,000 0
Acquisition of certain businesses, net of cash acquired (148,706) (50,194) (322,822)
Acquisition of certain equity investments (34,185) (4,000) (64,000)
Proceeds from sale of equity investments 101,198 633,179 0
Other investing activities (3,757) 40,147 15,510
Net cash (used in) provided by investing activities of Continuing Operations (415,862) 223,658 (745,154)
Cash flows from financing activities of Continuing Operations:      
Proceeds from long-term borrowings 571,288 1,286,526 100,051
Payments of long-term borrowings (2,003,566) (1,902,245) (124,297)
Net change in funding under the Receivables Facility 0 (104,935) 104,935
Payments of dividends (99,901) (114,614) (113,120)
Distribution from Vestis 0 1,456,701 0
Proceeds from issuance of common stock 36,573 45,602 42,954
Other financing activities (65,590) (7,408) (45,107)
Net cash (used in) provided by financing activities of Continuing Operations (1,561,196) 659,627 (34,584)
Discontinued Operations:      
Net cash provided by operating activities 0 254,782 230,586
Net cash used in investing activities 0 (14,746) (86,133)
Net cash provided by (used in) financing activities 0 3,322 (21,673)
Net cash provided by Discontinued Operations 0 243,358 122,780
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 10,790 4,697 (28,657)
(Decrease) increase in cash and cash equivalents and restricted cash (1,239,754) 1,642,987 (221,702)
Cash and cash equivalents and restricted cash, beginning of period, excluding cash of discontinued operations [1] 1,972,367    
Cash and cash equivalents and restricted cash, end of period, excluding cash of discontinued operations 732,613 1,972,367 [1]  
Cash and cash equivalents and restricted cash, beginning of period 2,008,418 365,431 [1] 587,133 [1]
Cash and cash equivalents and restricted cash, end of period 732,613 $ 2,008,418 $ 365,431 [1]
Cash and cash equivalents in current assets of discontinued operations $ 36,100    
[1]
(1) As a result of the separation and distribution of the Uniform segment, "Cash and cash equivalents and restricted cash, beginning of period" for fiscal 2024 excludes the fiscal 2023 "Cash and cash equivalents in Current assets of discontinued operations" of $36.1 million.